Author Correction:Pharmacokinetics,mass balance,and metabolism of[^(14)C]vicagrel,a novel irreversible P2Y_(12)inhibitor in humans  

作　　者：Yuan-dong Zheng Hua Zhang Yan Zhan Yi-cong Bian Sheng Ma Hai-xian Gan Xiao-juan Lai Yong-qiang Liu Yan-chun Gong Xue-fang Liu Hong-bin Sun Yong-guo Li Da-fang Zhong Li-yan Miao Xing-xing Diao 

机构地区：[1]State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201210,China [2]University of Chinese Academy of Sciences,Beijing 100049,China [3]Department of Clinical Pharmacology,the First Affiliated Hospital of Soochow University,Suzhou 215123,China [4]Institute for Interdisciplinary Drug Research and Translational Sciences,Soochow University,Suzhou 215006,China [5]Jiangsu Vcare PharmaTech Co.Ltd.,Nanjing 211800,China [6]State Key Laboratory of Natural Medicines and Center of Drug Discovery,College of Pharmacy,China Pharmaceutical University,Nanjing 210009,China [7]Guangzhou JOYO Pharma Ltd.,Shanghai 201203,China

出　　处：《Acta Pharmacologica Sinica》2023年第12期2549-2549,共1页中国药理学报（英文版）

摘　　要：The authors apologized for the mistake in Fig.3b,the mean concentration of metabolites M3,M9-2,M15-1,and M15-2 in plasma were provided incorrectly.These errors were made completely by accident.

关 键 词：METABOLISM IRREVERSIBLE MISTAKE 

分 类 号：R737.14[医药卫生—肿瘤]